Molecular chaperone alpha-crystallin prevents detrimental effects of neuroinflammation.
Silver nitrate administration stimulates immune activation, inflammation and deterioration in cell function. It is well established that hippocampal and cortical tissue are susceptible to degeneration in responses to insult such as oxidative stress or infection. This study was designed to investigate the prophylactic effect of alpha-crystallin, a major chaperone lens protein comprising of alpha-A and alpha-B subunits in inflammation induced mice. Mice were divided into three groups (n=6 in each), control, inflammation and alpha-crystallin treated. Our result shows that alpha-crystallin pretreatment effectively diminished systemic inflammation induced glial fibrillary acidic protein (GFAP) and nuclear factor kappa B (NFkappaB) expression in the mice neocortex, reversed elevated intracellular calcium levels, acetylcholine esterase activity and depletion of glucose. Furthermore it also significantly prevented nitric oxide (P<0.05) and lipid peroxide production in the plasma, liver, neocortex and hippocampus of the inflammation-induced mice. In order to demonstrate the direct *OH and nitric oxide radical scavenging ability of alpha-crystallin, an In vitro experiment using primary astrocyte culture subjected to lipopolysaccharide (LPS), a well-known inflammatory stimuli were also carried out. This study reiterates that alpha-crystallin therapy may serve as a potent pharmacological agent in neuroinflammation.
Masilamoni
J G
JG
Bio-Organic and Neurochemistry Laboratory, Central Leather Research Institute, Adyar, Chennai-600 020, India.
Jesudason
E P
EP
Baben
B'joe
B
Jebaraj
Charles E
CE
Dhandayuthapani
S
S
Jayakumar
R
R
D000109:Acetylcholine / Q000378:metabolism; D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002417:Cattle; D002478:Cells, Cultured; D003497:Cyclic N-Oxides / Q000378:metabolism; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D022781:Hepatocytes / Q000166:cytology / Q000378:metabolism; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control; D008214:Lymphocytes / Q000166:cytology / Q000378:metabolism; D008297:Male; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D018696:Neuroprotective Agents / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism; D012835:Silver Nitrate / Q000494:pharmacology; D013113:Spin Labels; D038201:alpha-Crystallins / Q000378:metabolism*
D003497:Cyclic N-Oxides; D005904:Glial Fibrillary Acidic Protein; D016328:NF-kappa B; D018696:Neuroprotective Agents; D013113:Spin Labels; D038201:alpha-Crystallins; D009569:Nitric Oxide; C069977:2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy; D012835:Silver Nitrate; D000110:Acetylcholinesterase; D005947:Glucose; D000109:Acetylcholine; D002118:Calcium